Recombinant Human Macrophage-Derived Chemokine/CCL22 (Human MDC/CCL22)-细胞/细菌培养-试剂-生物在线
Recombinant Human Macrophage-Derived Chemokine/CCL22 (Human MDC/CCL22)

Recombinant Human Macrophage-Derived Chemokine/CCL22 (Human MDC/CCL22)

商家询价

产品名称: Recombinant Human Macrophage-Derived Chemokine/CCL22 (Human MDC/CCL22)

英文名称: Recombinant Human Macrophage-Derived Chemokine/CCL22 (Human MDC/CCL22)

产品编号: 90967ES08

产品价格: 0

产品产地: Yeasen

品牌商标: Yeasen

更新时间: 2023-08-17T13:40:59

使用范围: null

翌圣生物科技(上海)股份有限公司
  • 联系人 : 李自转
  • 地址 : 上海市浦东新区天雄路166弄一号楼三层南单元
  • 邮编 : 200030
  • 所在区域 : 上海
  • 电话 : 139****5640
  • 传真 : 021-34615995-188
  • 邮箱 : lizizhuan@yeasen.com

 

  • Product Information

     

    Product Name

    Cat#

    Size

    Price¥

    Recombinant Human Macrophage-Derived Chemokine/CCL22 (Human MDC/CCL22)

    90967ES08

    5 μg

    815.00

    90967ES60

    100 μg

    7865.00

    90967ES76

    500 μg

    20425.00

     

    Product Description

     

    CCL22 is a protein that in humans is encoded by the CCL22 gene, which locates on the Chr. 16. The protein is highly expressed in macrophage, monocyte-derived dendritic cell and thymus, additionally, also detected in the tissues of thymus, lymph node and appendix. CCL22 can bind to CCR4, and is a chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells, but not for neutrophils, eosinophils, and resting T-lymphocytes. After secreted from monocyte-derived dendritic cells, the protein can be proteolytic cleaved into three forms: MDC (3-69), MDC (5-69), MDC (7-69).

     

    Product Properties

     

    Synonyms

    A-152E5.1n ABCD-1; DC/B-CK; MDC ; SCYA22 ; STCP-1

    Accession

    O00626

    GeneID

    6367

    Source

    E.coli-derived human Macrophage-Derived Chemokine Protein, Gly25-Gln93

    Molecular Weight

    Approximately 8.1 kDa.

    AA Sequence

    GPYGANMEDS VCCRDYVRYR LPLRVVKHFY WTSDSCPRPG VVLLTFRDKE ICADPRVPWV KMILNKLSQ

    Tag

    None

    Physical Appearance

    Sterile Filtered White lyophilized (freeze-dried) powder.

    Purity

    > 97 % by SDS-PAGE and HPLC analyses.

    Biological Activity

    Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human T-lymphocytes is in a concentration range of 10-100 ng/ml.

    Endotoxin

    <1.0 EU per 1μg of the protein by the LAL method.

    Formulation

    Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH7.4, 500 mM NaCl.

    Reconstitution

    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

     

    Shipping and Storage

     

    The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.

    Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.


    Cautions

     

    1. Avoid repeated freeze-thaw cycles.

    2. For your safety and health, please wear lab coats and disposable gloves for operation.

    3. For research use only.

                                                                                              

        HB220505